Covid drug: Natco eyes patent waiver

In its application, Natco has cited the unmet medical needs due to the lack of supply and affordability in light of the grave and life-threatening national public health emergency caused by the second Covid wave as the main grounds for seeking the compulsory licensing .

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3eVa3CV
via IFTTT

0 comments:

Post a Comment